| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |